Nanox Imaging Ltd. (NASDAQ: NNOX) announced a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement positions Nanox to enter its third Latin American market this year, following earlier moves into Argentina and Peru, as the company seeks to drive the world’s transition to preventive health care.
Under the terms of the agreement, SOLME will oversee marketing, distribution, installation, training and ongoing technical support in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country’s principal purchaser and provider of hospital services. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. The agreement is detailed in a press release available at https://ibn.fm/C77lJ.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. It is part of the broader Nanox ecosystem, which combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The ecosystem includes Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
This expansion into Costa Rica is significant because it demonstrates Nanox’s strategy to penetrate Latin American markets, where access to advanced medical imaging can be limited. By partnering with SOLME, a supplier to the CCSS, Nanox aims to integrate its technology into the country’s public healthcare system. The CCSS is the primary provider of hospital services in Costa Rica, and its adoption of the Nanox.ARC could substantially increase the availability of 3D imaging for patients who might otherwise lack access. The proof-of-concept registration period allows for clinical validation before full commercialization, potentially building confidence among local healthcare providers and regulators.
For investors, the agreement signals progress in Nanox’s global commercialization efforts. The company’s vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes. The latest news and updates relating to NNOX are available in the company’s newsroom at http://ibn.fm/NNOX.
BioMedWire is a specialized communications platform with a focus on the latest developments in the Biotechnology, Biomedical Sciences and Life Sciences sectors. For more information, visit https://www.BioMedWire.com. The full terms of use and disclaimers are available at https://www.BioMedWire.com/Disclaimer.
